Literature DB >> 15920767

Measurement of drug release from microcarriers by microdialysis.

Cory J Hitzman1, Timothy S Wiedmann, Haiqing Dai, William F Elmquist.   

Abstract

The purpose of this study was to examine the feasibility of the microdialysis sampling technique as a method to precisely and conveniently measure drug release from microcarrier systems such as liposomes and microspheres. Release of 5-fluorouracil (5-FU) from liposomes and microspheres was evaluated in vitro using microdialysis. Retrodialysis calibration using 5-chlorouracil (5-CU) was performed in conjunction with on-line HPLC analysis. At a microdialysis perfusate flow rate of 0.5 muL/min, concurrent 5-FU gain and 5-CU loss ranged from 72% to 75%, while concurrent 5-FU loss and 5-CU ranged from 69% to 71%. After calibration, simultaneous 5-FU release profiles were obtained by continuous microdialysis and discrete equilibrium dialysis sampling using a side-by-side diffusion apparatus. Release rates were characterized by a first-order release model. The release rate constants for a representative liposomal formulation were 0.30 and 1.85/h by microdialysis in the acceptor and donor compartments, respectively, and 0.39/h by equilibrium dialysis in the acceptor compartment. The calculated release rate constant determined by equilibrium dialysis in the donor compartment (1.98/h) agrees with that determined by microdialysis (1.85/h) when the resistance of the equilibrium dialysis membrane with associated first-order rate constant of transfer of 0.42/h is taken into account. Release profiles of 5-FU from a number of different liposome and microsphere formulations were determined. The results indicate that a convenient and reproducible characterization of drug release from various liposome and microsphere formulations is readily obtainable by microdialysis. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920767     DOI: 10.1002/jps.20349

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.

Authors:  Wenmin Yuan; Rui Kuai; Zhipeng Dai; Yue Yuan; Nan Zheng; Wenlei Jiang; Charles Noble; Mark Hayes; Francis C Szoka; Anna Schwendeman
Journal:  AAPS J       Date:  2016-08-02       Impact factor: 4.009

Review 2.  Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective.

Authors:  Deepak Solomon; Nilesh Gupta; Nihal S Mulla; Snehal Shukla; Yadir A Guerrero; Vivek Gupta
Journal:  AAPS J       Date:  2017-09-18       Impact factor: 4.009

3.  Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.

Authors:  Diego Fontana de Andrade; Carine Zuglianello; Adriana Raffin Pohlmann; Silvia Stanisçuaski Guterres; Ruy Carlos Ruver Beck
Journal:  AAPS PharmSciTech       Date:  2015-05-19       Impact factor: 3.246

4.  Simultaneous intra-accumbens remifentanil and dopamine kinetics suggest that neither determines within-session operant responding.

Authors:  Jose A Crespo; Katja Sturm; Alois Saria; Gerald Zernig
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

5.  Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.

Authors:  Sihem Ait-Oudhia; Donald E Mager; Robert M Straubinger
Journal:  Pharmaceutics       Date:  2014-03-18       Impact factor: 6.321

6.  Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery.

Authors:  Susan Hua
Journal:  Int J Nanomedicine       Date:  2014-01-30

Review 7.  Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems.

Authors:  José L Arias
Journal:  Molecules       Date:  2008-10-01       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.